115 related articles for article (PubMed ID: 3150113)
1. The effects of lipoxygenase inhibitor and peptidoleukotriene antagonist on myocardial injury in a canine coronary occlusion-reperfusion model.
Toki Y; Hieda N; Torii T; Hashimoto H; Ito T; Ogawa K; Satake T
Prostaglandins; 1988 Apr; 35(4):555-71. PubMed ID: 3150113
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of a thromboxane synthetase inhibitor, a thromboxane antagonist, a lipoxygenase inhibitor and a leukotriene C4, D4 antagonist on myocardial injury caused by acute myocardial infarction in the canine heart.
Ito T; Toki Y; Hieda N; Okumura K; Hashimoto H; Ogawa K; Satake T
Jpn Circ J; 1989 Sep; 53(9):1115-21. PubMed ID: 2513429
[TBL] [Abstract][Full Text] [Related]
3. Myocardial salvage by a novel thromboxane A2 synthetase inhibitor in a canine coronary occlusion-reperfusion model.
Toki Y; Hieda N; Okumura K; Hashimoto H; Ito T; Ogawa K; Satake T
Arzneimittelforschung; 1988 Feb; 38(2):224-7. PubMed ID: 3370068
[TBL] [Abstract][Full Text] [Related]
4. Effects of a thromboxane synthetase inhibitor, Y-20811, on infarct size, neutrophil accumulation, and arrhythmias after coronary artery occlusion and reperfusion in dogs.
Sato N; Endo T; Kiuchi K; Hayakawa H
J Cardiovasc Pharmacol; 1993 Mar; 21(3):353-61. PubMed ID: 7681494
[TBL] [Abstract][Full Text] [Related]
5. Effects of a new thromboxane A2-antagonist (ONO-3708) and a new leukotriene-antagonist (ONO-1078) on thromboxane A2 analogue-, leukotriene C4-, and D4-induced regional myocardial blood flow reduction.
Torii T; Toki Y; Hieda N; Ito Y; Okumura K; Hashimoto H; Ito T; Ogawa K; Satake T
Heart Vessels; 1988; 4(2):104-11. PubMed ID: 3253270
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of a novel thromboxane antagonist, BAY-U3405, on canine myocardial damage after coronary artery occlusion and reperfusion.
Fiedler VB; Perzborn E; Seuter F
Pharmacotherapy; 1991; 11(1):77-84. PubMed ID: 2020615
[TBL] [Abstract][Full Text] [Related]
7. Infarct salvage with liposomal prostaglandin E1 administered by intravenous bolus immediately before reperfusion in a canine infarction-reperfusion model.
Smalling RW; Feld S; Ramanna N; Amirian J; Felli P; Vaughn WK; Swenson C; Janoff A
Circulation; 1995 Aug; 92(4):935-43. PubMed ID: 7641377
[TBL] [Abstract][Full Text] [Related]
8. Does preconditioning protect the coronary vasculature from subsequent ischemia/reperfusion injury?
Bauer B; Simkhovich BZ; Kloner RA; Przyklenk K
Circulation; 1993 Aug; 88(2):659-72. PubMed ID: 8339428
[TBL] [Abstract][Full Text] [Related]
9. Attenuation of neutrophil function by inhibitors of arachidonate metabolism reduces the extent of canine myocardial infarction.
Hoshida S; Kuzuya T; Nishida M; Kim Y; Kitabatake A; Kamada T; Tada M
Am J Cardiol; 1989 Mar; 63(10):24E-28E. PubMed ID: 2493731
[TBL] [Abstract][Full Text] [Related]
10. Role of Na(+)-H+ exchange on reperfusion related myocardial injury and arrhythmias in an open-chest swine model.
Fukuta M; Wakida Y; Iwa T; Uesugi M; Kobayashi T
Pacing Clin Electrophysiol; 1996 Nov; 19(11 Pt 2):2027-33. PubMed ID: 8945091
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic perturbation of neutrophils by Fluosol results in a sustained reduction in infarct size in the canine model of reperfusion.
Forman MB; Pitarys CJ; Vildibill HD; Lambert TL; Ingram DA; Virmani R; Murray JJ
J Am Coll Cardiol; 1992 Jan; 19(1):205-16. PubMed ID: 1729335
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the Na(+)/H(+) exchanger attenuates phase 1b ischemic arrhythmias and reperfusion-induced ventricular fibrillation.
Gumina RJ; Daemmgen J; Gross GJ
Eur J Pharmacol; 2000 May; 396(2-3):119-24. PubMed ID: 10822064
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of LY203647 on cardiovascular leukotriene D4 receptors and myocardial reperfusion injury.
Hahn RA; MacDonald BR; Morgan E; Potts BD; Parli CJ; Rinkema LE; Whitesitt CA; Marshall WS
J Pharmacol Exp Ther; 1992 Mar; 260(3):979-89. PubMed ID: 1312172
[TBL] [Abstract][Full Text] [Related]
14. Limitation of myocardial infarct size in pigs with a dual lipoxygenase-cyclooxygenase blocking agent by inhibition of neutrophil activity without reduction of neutrophil migration.
Amsterdam EA; Pan HL; Rendig SV; Symons JD; Fletcher MP; Longhurst JC
J Am Coll Cardiol; 1993 Nov; 22(6):1738-44. PubMed ID: 8227848
[TBL] [Abstract][Full Text] [Related]
15. U74006F, a novel 21-aminosteroid, inhibits in vivo lipid peroxidation but fails to limit infarct size in a canine model of myocardial ischemia reperfusion.
Ovize M; de Lorgeril M; Ovize A; Ciavatti M; Delaye J; Renaud S
Am Heart J; 1991 Sep; 122(3 Pt 1):681-9. PubMed ID: 1877444
[TBL] [Abstract][Full Text] [Related]
16. Effects of KR-32570, a new sodium hydrogen exchanger inhibitor, on myocardial infarction and arrhythmias induced by ischemia and reperfusion.
Lee BH; Yi KY; Lee S; Lee S; Yoo SE
Eur J Pharmacol; 2005 Oct; 523(1-3):101-8. PubMed ID: 16226744
[TBL] [Abstract][Full Text] [Related]
17. Reduction of myocardial ischemia-reperfusion injury by KT-362, a new intracellular calcium antagonist in anesthetized dogs.
Pelc LR; Farber NE; Warltier DC; Gross GJ
J Cardiovasc Pharmacol; 1989 Apr; 13(4):586-93. PubMed ID: 2470996
[TBL] [Abstract][Full Text] [Related]
18. Myocardial salvage induced by REV-5901: an inhibitor and antagonist of the leukotrienes.
Mullane K; Hatala MA; Kraemer R; Sessa W; Westlin W
J Cardiovasc Pharmacol; 1987 Oct; 10(4):398-406. PubMed ID: 2444792
[TBL] [Abstract][Full Text] [Related]
19. Selective antagonism of peptidoleukotriene responses does not reduce myocardial damage or neutrophil accumulation following coronary artery occlusion with reperfusion.
Egan JW; Griswold DE; Hillegass LM; Newton JF; Eckardt RD; Slivjak MJ; Smith EF
Prostaglandins; 1989 May; 37(5):597-613. PubMed ID: 2544926
[TBL] [Abstract][Full Text] [Related]
20. Bimakalim, an ATP-sensitive potassium channel opener, mimics the effects of ischemic preconditioning to reduce infarct size, adenosine release, and neutrophil function in dogs.
Mizumura T; Nithipatikom K; Gross GJ
Circulation; 1995 Sep; 92(5):1236-45. PubMed ID: 7648671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
